ABBV vs GSK: Which Is the Better Dividend Stock?
As of July 2026, ABBV (AbbVie Inc.) screens as the stronger dividend stock, winning 6 of 8 head-to-head metrics. GSK offers the higher yield at 3.50%, ABBV has the higher dividend-safety score, and ABBV trades at the larger discount to fair value (+14%).
| Metric | ABBV | GSK |
|---|---|---|
| Forward yield | 2.69% | 3.50% |
| Annual dividend | $6.92 | $1.80 |
| Payout ratio | 326% | 47% |
| Years of growth | 12 yr | 2 yr |
| 5-yr dividend growth | 6.8% | -4.0% |
| 5-yr total return | 115% | 26% |
| Dividend safety score | 79 (B) | 54 (C) |
| Fair value estimate | $296.35 | $56.55 |
| Upside to fair value | +14% | +10% |
| Frequency | quarterly | quarterly |
| Market cap | $458.2B | $102.8B |
| P/E ratio | 126.5 | 13.5 |
Higher yield
GSK
3.50%
Safer dividend
ABBV
Grade B
Faster growth
ABBV
6.8%
Better value
ABBV
+14% upside
ABBV vs GSK — FAQ
Related comparisons
See more dividend stock comparisons · data refreshes daily · for informational purposes only, not investment advice.